查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088037

預防性醫療保健解決方案市場預測至2034年－按服務類型、技術整合、交付模式、最終用戶和地區分類的全球分析

Preventive Healthcare Solutions Market Forecasts to 2034 - Global Analysis By Service Type, Technology Integration, Delivery Model, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球預防性醫療保健解決方案市場規模將達到 4,126 億美元，在預測期內以 12.5% 的複合年成長率成長，到 2034 年將達到 1.0586 兆美元。

預防性醫療保健解決方案旨在透過早期診斷、定期體檢、疫苗接種和健康的生活方式來最大限度地減少疾病爆發。這些方案優先考慮預防性照護而非以治療為中心的方法，有助於人們更長時間地保持健康，同時也有助於降低醫療成本。這些解決方案融合了數位追蹤工具、穿戴式科技、營養指導和定期健康評估。醫療保健系統、政府和組織正在積極推廣預防性醫療保健模式，以改善整體公共衛生狀況。人們對慢性病和早期療育的認知不斷提高，並持續推動全球預防性醫療保健系統的普及，如今，這些系統已成為全球現代醫療保健基礎設施不可或缺的一部分，有助於提升醫療效果。

根據世界衛生組織（2023 年世界衛生統計）的數據，全球免疫計劃每年可預防約 400 萬人死亡，這表明預防性醫療保健解決方案對降低死亡率和醫療保健成本具有可衡量的影響。

慢性病盛行率上升

預防性醫療保健解決方案市場的主要促進因素之一是糖尿病、心臟病、肥胖和呼吸系統疾病等慢性疾病發生率的上升。由於這些疾病通常進展緩慢，早期發現和預防至關重要。因此，個人和醫療保健系統擴大實施定期體檢、健康追蹤和生活方式改善計劃。慢性疾病在全球範圍內日益加重，也導致醫療保健成本飆升，促使各國政府和組織將預防策略列為優先事項。這種對早期療育意識的提高和重視，正在加速全球人群對預防性醫療保健解決方案的採用，從而最終改善整體長期健康。

預防性醫療保健服務高成本

預防性醫療保健解決方案市場面臨的主要限制因素之一是預防性服務的高昂成本。先進的診斷測試、持續健康監測設備和定期體檢的費用可能造成沉重的負擔，尤其是在開發中國家和低收入地區。由於經濟拮据，許多人往往更注重眼前的治療需求，而非投資長期預防。此外，保險對預防性醫療保健的支持不足，進一步加重了個人的醫療負擔。這些經濟挑戰限制了人們獲得預防性醫療保健解決方案的機會，並減緩了其普及速度。因此，成本相關的障礙仍然是全球各地不同人群市場成長的主要限制因素。

數位健康和​​穿戴式科技的擴展

數位醫療工具和穿戴式裝置的日益普及為預防性醫療解決方案市場創造了巨大的機會。智慧型穿戴裝置、健身手環和遠端監測系統使用戶能夠持續追蹤自身健康狀況，並及早發現潛在風險。這些設備監測心率、睡眠品質和活動量等關鍵指標，從而實現主動健康管理。智慧型手機的普及和網路存取的改善進一步加速了數位健康平台的推廣應用。醫療服務提供者可以分析收集到的數據，從而做出更準確的預測並制定個人化的治療方案。這些技術進步正在有效地促進全球人口對預防性醫療的接受度。

開發中國家和農村地區的普及率較低。

農村和發展中地區對預防性醫療保健解決方案的接受度有限，對市場成長構成重大威脅。健康意識低下、醫療基礎設施薄弱以及經濟拮据限制了這些地區獲得預防性醫療保健服務的機會。許多人由於缺乏相關知識和經濟顧慮，只專注於生病後的治療，而忽略了預防保健。此外，網路連線不良和難以取得最新醫療技術也進一步阻礙了預防性醫療保健解決方案的推廣。訓練有素的醫療保健專業人員短缺也限制了支援服務的擴展。這種醫療保健服務分配不均的狀況正在減緩預防性醫療保健解決方案在全球的普及。

新型冠狀病毒（COVID-19）的影響：

新冠疫情提升了全球對疾病預防、早期檢測和持續健康監測的重視程度，對預防性醫療保健解決方案市場產生了顯著影響。世界各國政府和醫療機構紛紛推廣疫苗接種計畫、衛生措施、定期體檢和遠端監測，以遏制病毒傳播。這導致遠端醫療服務、數位健康平台和穿戴式科技的需求激增。人們更加重視自身健康，加速了預防性醫療保健解決方案的普及。然而，供應鏈中斷和非必要醫療服務的延遲暫時減緩了市場活動。儘管面臨這些挑戰，疫情仍顯著加速了全球向預防性醫療保健的長期轉變。

在預測期內，篩檢和診斷領域預計將佔據最大的市場佔有率。

預計在預測期內，篩檢和診斷領域將佔據最大的市場佔有率，因為它對疾病的早期識別至關重要。該領域包括常規健康檢查、臨床檢測、影像技術以及先進的診斷技術，這些技術能夠及時發現疾病，防止病情惡化。人們對預防醫學的日益重視以及慢性病負擔的加重，正在推動對這些服務的需求。在醫療保健系統中，早期診斷被優先考慮，以最大限度地降低治療成本並提高康復率。診斷技術的不斷進步也提高了診斷的準確性和可近性。

在預測期內，「雇主和企業客戶」細分市場預計將呈現最高的複合年成長率。

在預測期內，「雇主和企業客戶」細分市場預計將呈現最高的成長率，這主要得益於企業對員工健康和生產力的日益重視。企業正擴大採用預防性醫療保健計劃，以最大限度地減少員工缺勤、提高效率並控制醫療成本。這些計劃通常包括定期健康檢查、心理健康支援、健身活動和生活方式改善服務。人們普遍認知到員工福祉與績效之間的聯繫，這正在加速這些計劃的實施。此外，與醫療保健提供者和保險公司的合作正在加強企業健康生態系統，使該細分市場成為全球成長最快的細分市場。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高度發展的醫療保健體系、高額的醫療費用支出以及民眾對預防醫學的高度重視。數位健康工具、穿戴式科技和定期健康檢查計畫在該地區廣泛應用。政府的支持政策和預防性服務的保險覆蓋範圍進一步推動了這些技術的普及。此外，該地區擁有眾多領先的醫療機構、創新者和先進的診斷基礎設施，這也鞏固了其市場主導地位。慢性病盛行率的不斷上升正在推動對早期診斷和預防策略的需求。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於其龐大的人口基數、不斷提高的健康意識以及醫療基礎設施的持續發展。在中國、印度和日本等主要國家，慢性病和文明病負擔的加重正在推動預防性醫療保健的需求。政府主導的免疫接種、健康體檢和數位醫療推廣計畫正在推動市場擴張。可支配收入的增加和醫療費用支出的成長正在改善人們獲得醫療服務的途徑。此外，行動醫療應用和遠端醫療的快速發展也顯著促進了都市區地區預防性醫療保健的普及。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球預防性醫療保健解決方案市場：按服務類型分類

  • 健康風險評估
  • 篩檢和診斷
  • 疫苗接種和免疫計劃
  • 生活方式和健康管理
  • 慢性病預防計劃

第6章：全球預防性醫療保健解決方案市場：依技術整合分類

  • 數位健康平台
  • 穿戴式和遠端監控設備
  • 人工智慧和預測分析工具
  • 遠端醫療與虛擬預防醫學
  • 基因組學與個人化預防醫學

第7章 全球預防性醫療保健解決方案市場：依產品模式分類

  • 醫院主導的預防項目
  • 基層醫療診所和醫生網路
  • 企業和職場的健康計劃
  • 社區和公共衛生舉措
  • 居家預防保健

第8章 全球預防性醫療保健解決方案市場：按最終用戶分類

  • 個人和家庭
  • 雇主和企業客戶
  • 醫療服務提供方
  • 付款人和保險公司
  • 政府和公共衛生機構

第9章 全球預防性醫療保健解決方案市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Abbott Laboratories
  • Medtronic plc
  • Siemens Healthineers
  • GE HealthCare Technologies Inc.
  • Philips
  • Laboratory Corporation of America Holdings（Labcorp）
  • Merck & Co., Inc.
  • GlaxoSmithKline plc（GSK）
  • Myriad Genetics, Inc.
  • Omron Healthcare, Inc.
  • Teladoc Health, Inc.
  • UnitedHealth Group（Optum）
  • McKesson Corporation
  • Omnicell, Inc.
  • Becton Dickinson（BD）
  • Hologic, Inc.
  • iRhythm Technologies, Inc.
  • Guardant Health, Inc.
Product Code: SMRC37809

According to Stratistics MRC, the Global Preventive Healthcare Solutions Market is accounted for $412.6 billion in 2026 and is expected to reach $1058.6 billion by 2034 growing at a CAGR of 12.5% during the forecast period. Preventive Healthcare Solutions aim to minimize disease occurrence by focusing on early diagnosis, routine screenings, immunization, and healthy lifestyle practices. They prioritize proactive care over treatment-based approaches helping people stay healthier for longer periods while lowering medical expenses. These solutions incorporate digital tracking tools wearable technologies nutrition guidance and regular health assessments. Healthcare systems governments and organizations are actively encouraging preventive care models to enhance overall public health outcomes. Growing awareness about chronic illnesses and early intervention continues to drive global adoption of preventive healthcare systems making it a vital part of modern healthcare infrastructure worldwide today for better outcomes.

According to WHO (World Health Statistics 2023), global immunization programs prevented an estimated 4 million deaths annually, demonstrating the measurable impact of preventive healthcare solutions in reducing mortality and healthcare costs.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

A key factor driving the Preventive Healthcare Solutions market is the rising incidence of long-term illnesses like diabetes, heart disease, obesity, and respiratory disorders. These conditions typically progress gradually, making early identification and prevention crucial. As a result, individuals and healthcare systems are increasingly adopting routine screenings, wellness tracking, and lifestyle improvement programs. The escalating global burden of chronic diseases is also pushing healthcare costs higher, prompting authorities and organizations to emphasize preventive strategies. This growing awareness and focus on early intervention are accelerating the adoption of preventive healthcare solutions across global populations and improving long-term health outcomes overall.

Restraint:

High cost of preventive healthcare services

A significant limitation in the Preventive Healthcare Solutions market is the high expense associated with preventive services. Costs of advanced diagnostic tests, continuous health monitoring devices, and routine medical screenings can be burdensome, particularly in developing and lower-income regions. Many individuals tend to focus on immediate treatment needs rather than investing in long-term prevention due to financial constraints. Limited insurance support for preventive care further increases personal healthcare spending. These affordability challenges reduce accessibility and slow down the adoption of preventive healthcare solutions. Consequently, cost-related barriers remain a key factor restricting market expansion across various global populations and regions.

Opportunity:

Expansion of digital health and wearable technologies

The growing adoption of digital healthcare tools and wearable devices creates a strong opportunity for the Preventive Healthcare Solutions market. Smart wearables, fitness bands, and remote monitoring systems allow users to continuously track their health conditions and identify potential risks early. These devices monitor key indicators such as heart rate, sleep quality, and activity levels, enabling proactive health management. Rising smartphone usage and improved internet access further accelerate the use of digital health platforms. Healthcare providers can analyze collected data for better predictions and personalized treatment plans. This technological expansion is driving preventive healthcare adoption across global populations effectively.

Threat:

Low adoption in developing and rural regions

Limited acceptance of preventive healthcare solutions in rural and developing regions poses a major threat to market growth. Factors such as low health awareness, weak medical infrastructure, and financial limitations reduce the use of preventive services in these areas. Many individuals focus on treating illnesses only when they occur rather than investing in preventive care due to lack of knowledge and affordability concerns. In addition, poor digital connectivity and limited access to modern healthcare technologies further hinder adoption. A shortage of trained medical professionals also restricts outreach efforts. This uneven distribution of healthcare access slows the global expansion of preventive healthcare solutions.

Covid-19 Impact:

The COVID-19 outbreak greatly influenced the Preventive Healthcare Solutions market by raising global awareness about disease prevention, early detection, and continuous health monitoring. Governments and healthcare bodies promoted vaccination programs, hygiene measures, routine screenings, and remote monitoring to manage virus transmission. This led to a sharp rise in demand for telehealth services, digital health platforms, and wearable technologies. Individuals became more conscious of maintaining their health, boosting adoption of preventive care solutions. However, supply chain disruptions and postponement of non-essential medical services temporarily slowed market activities. Despite challenges, the pandemic significantly accelerated the long-term shift toward preventive healthcare adoption globally.

The screening & diagnostics segment is expected to be the largest during the forecast period

The screening & diagnostics segment is expected to account for the largest market share during the forecast period because it is essential for identifying diseases at an early stage. It covers regular medical examinations, laboratory testing, imaging techniques, and modern diagnostic technologies that enable timely detection before conditions worsen. Rising awareness of preventive healthcare and the increasing burden of chronic illnesses are boosting demand for these services. Healthcare systems prioritize early diagnosis to minimize treatment expenses and improve recovery rates. Continuous improvements in diagnostic technologies also enhance precision and availability.

The employers & corporate clients segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the employers & corporate clients segment is predicted to witness the highest growth rate, driven by the rising emphasis on workforce health and productivity improvement. Organizations are increasingly adopting preventive healthcare initiatives to minimize employee absenteeism, enhance efficiency, and control healthcare-related expenses. These programs typically include routine medical screenings, mental wellness support, physical fitness activities, and lifestyle improvement services. Growing recognition of the connection between employee well-being and business performance is accelerating adoption. In addition, collaborations with healthcare providers and insurance firms are strengthening corporate wellness ecosystems, making this segment the fastest expanding globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to its highly developed healthcare system, substantial healthcare expenditure, and strong emphasis on preventive care awareness. The region shows widespread use of digital health tools, wearable technologies, and routine medical screening programs. Supportive government policies and insurance coverage for preventive services further boost adoption. A strong presence of leading healthcare organizations, technology innovators, and advanced diagnostic infrastructure also contributes to market leadership. Increasing cases of chronic diseases drive demand for early diagnosis and preventive strategies.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by its vast population, increasing health awareness, and ongoing development of healthcare infrastructure. Major countries like China, India, and Japan are experiencing rising demand for preventive healthcare due to the growing burden of chronic and lifestyle-related diseases. Government-led programs focusing on vaccination, health checkups, and digital health adoption are driving market expansion. Increasing disposable incomes and improved healthcare spending are enhancing access to services. Additionally, rapid growth in mobile health applications and telemedicine is significantly boosting preventive healthcare adoption across both urban and rural regions.

Key players in the market

Some of the key players in Preventive Healthcare Solutions Market include Abbott Laboratories, Medtronic plc, Siemens Healthineers, GE HealthCare Technologies Inc., Philips, Laboratory Corporation of America Holdings (Labcorp), Merck & Co., Inc., GlaxoSmithKline plc (GSK), Myriad Genetics, Inc., Omron Healthcare, Inc., Teladoc Health, Inc., UnitedHealth Group (Optum), McKesson Corporation, Omnicell, Inc., Becton Dickinson (BD), Hologic, Inc., iRhythm Technologies, Inc. and Guardant Health, Inc.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Service Types Covered:

  • Health Risk Assessments
  • Screening & Diagnostics
  • Vaccination & Immunization Programs
  • Lifestyle & Wellness Management
  • Chronic Disease Prevention Programs

Technology Integrations Covered:

  • Digital Health Platforms
  • Wearable & Remote Monitoring Devices
  • AI & Predictive Analytics Tools
  • Telehealth & Virtual Preventive Care
  • Genomics & Personalized Preventive Medicine

Delivery Models Covered:

  • Hospital-Based Preventive Programs
  • Primary Care Clinics & Physician Networks
  • Corporate & Workplace Wellness Programs
  • Community & Public Health Initiatives
  • Home-Based Preventive Care

End Users Covered:

  • Individuals & Families
  • Employers & Corporate Clients
  • Healthcare Providers
  • Payers & Insurance Companies
  • Government & Public Health Agencies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Preventive Healthcare Solutions Market, By Service Type

  • 5.1 Health Risk Assessments
  • 5.2 Screening & Diagnostics
  • 5.3 Vaccination & Immunization Programs
  • 5.4 Lifestyle & Wellness Management
  • 5.5 Chronic Disease Prevention Programs

6 Global Preventive Healthcare Solutions Market, By Technology Integration

  • 6.1 Digital Health Platforms
  • 6.2 Wearable & Remote Monitoring Devices
  • 6.3 AI & Predictive Analytics Tools
  • 6.4 Telehealth & Virtual Preventive Care
  • 6.5 Genomics & Personalized Preventive Medicine

7 Global Preventive Healthcare Solutions Market, By Delivery Model

  • 7.1 Hospital-Based Preventive Programs
  • 7.2 Primary Care Clinics & Physician Networks
  • 7.3 Corporate & Workplace Wellness Programs
  • 7.4 Community & Public Health Initiatives
  • 7.5 Home-Based Preventive Care

8 Global Preventive Healthcare Solutions Market, By End User

  • 8.1 Individuals & Families
  • 8.2 Employers & Corporate Clients
  • 8.3 Healthcare Providers
  • 8.4 Payers & Insurance Companies
  • 8.5 Government & Public Health Agencies

9 Global Preventive Healthcare Solutions Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Abbott Laboratories
  • 12.2 Medtronic plc
  • 12.3 Siemens Healthineers
  • 12.4 GE HealthCare Technologies Inc.
  • 12.5 Philips
  • 12.6 Laboratory Corporation of America Holdings (Labcorp)
  • 12.7 Merck & Co., Inc.
  • 12.8 GlaxoSmithKline plc (GSK)
  • 12.9 Myriad Genetics, Inc.
  • 12.10 Omron Healthcare, Inc.
  • 12.11 Teladoc Health, Inc.
  • 12.12 UnitedHealth Group (Optum)
  • 12.13 McKesson Corporation
  • 12.14 Omnicell, Inc.
  • 12.15 Becton Dickinson (BD)
  • 12.16 Hologic, Inc.
  • 12.17 iRhythm Technologies, Inc.
  • 12.18 Guardant Health, Inc.

List of Tables

  • Table 1 Global Preventive Healthcare Solutions Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Preventive Healthcare Solutions Market Outlook, By Service Type (2023-2034) ($MN)
  • Table 3 Global Preventive Healthcare Solutions Market Outlook, By Health Risk Assessments (2023-2034) ($MN)
  • Table 4 Global Preventive Healthcare Solutions Market Outlook, By Screening & Diagnostics (2023-2034) ($MN)
  • Table 5 Global Preventive Healthcare Solutions Market Outlook, By Vaccination & Immunization Programs (2023-2034) ($MN)
  • Table 6 Global Preventive Healthcare Solutions Market Outlook, By Lifestyle & Wellness Management (2023-2034) ($MN)
  • Table 7 Global Preventive Healthcare Solutions Market Outlook, By Chronic Disease Prevention Programs (2023-2034) ($MN)
  • Table 8 Global Preventive Healthcare Solutions Market Outlook, By Technology Integration (2023-2034) ($MN)
  • Table 9 Global Preventive Healthcare Solutions Market Outlook, By Digital Health Platforms (2023-2034) ($MN)
  • Table 10 Global Preventive Healthcare Solutions Market Outlook, By Wearable & Remote Monitoring Devices (2023-2034) ($MN)
  • Table 11 Global Preventive Healthcare Solutions Market Outlook, By AI & Predictive Analytics Tools (2023-2034) ($MN)
  • Table 12 Global Preventive Healthcare Solutions Market Outlook, By Telehealth & Virtual Preventive Care (2023-2034) ($MN)
  • Table 13 Global Preventive Healthcare Solutions Market Outlook, By Genomics & Personalized Preventive Medicine (2023-2034) ($MN)
  • Table 14 Global Preventive Healthcare Solutions Market Outlook, By Delivery Model (2023-2034) ($MN)
  • Table 15 Global Preventive Healthcare Solutions Market Outlook, By Hospital-Based Preventive Programs (2023-2034) ($MN)
  • Table 16 Global Preventive Healthcare Solutions Market Outlook, By Primary Care Clinics & Physician Networks (2023-2034) ($MN)
  • Table 17 Global Preventive Healthcare Solutions Market Outlook, By Corporate & Workplace Wellness Programs (2023-2034) ($MN)
  • Table 18 Global Preventive Healthcare Solutions Market Outlook, By Community & Public Health Initiatives (2023-2034) ($MN)
  • Table 19 Global Preventive Healthcare Solutions Market Outlook, By Home-Based Preventive Care (2023-2034) ($MN)
  • Table 20 Global Preventive Healthcare Solutions Market Outlook, By End User (2023-2034) ($MN)
  • Table 21 Global Preventive Healthcare Solutions Market Outlook, By Individuals & Families (2023-2034) ($MN)
  • Table 22 Global Preventive Healthcare Solutions Market Outlook, By Employers & Corporate Clients (2023-2034) ($MN)
  • Table 23 Global Preventive Healthcare Solutions Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 24 Global Preventive Healthcare Solutions Market Outlook, By Payers & Insurance Companies (2023-2034) ($MN)
  • Table 25 Global Preventive Healthcare Solutions Market Outlook, By Government & Public Health Agencies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.